Balaji Amines opened higher at ₹2,074.00, compared with its previous close of ₹2,062.30. During today's session, the stock has traded between ₹2,022.10 and ₹2,090.00, with an average traded price of ₹2,049.33. It is currently showing an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Balaji Amines is now worth
₹ 4,643.00
resulting in a loss of
₹ 5,357.00 (53.57%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+21.70 (+1.05%)
Day High
₹2,090.00
Day Low
₹2,022.10
Day Open
₹2,074.00
Prev Close
₹2,062.30
Volume
1,06,863
Value Traded
₹21.90 Cr
1W Return
6.45%
1M Return
-8.46%
3M Return
-13.70%
6M Return
93.59%
1Y Return
52.28%
Market Cap (₹ Cr.)
6,752
PE Ratio
31.70
PB Ratio
3.38
Dividend Yield
0.53%
ROE
7.86%
ROCE
10.16%
Book Value (₹)
610.00
Face Value (₹)
2.00
EPS (TTM)
23.13
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
6.45%
6 Week
-
1 Month
-8.46%
3 Month
-13.70%
9 Month
89.30%
Balaji Amines shares worth ₹23.36 crore change hands in large trade
Approximately 99,455 shares of Balaji Amines changed hands on the NSE in a flagged large-trade signal. The shares were traded at ₹2,349.30, with a combined value of ₹23.36 crore. This is a real-time signal from a trade-scanning system, not a confirmed exchange-reported event. Buyer, seller, and broker identities are not known until official exchange disclosure after market close.
7 days agoSEBI warns Balaji Amines for delayed DGFT and FDA disclosures
SEBI issued a Warning cum Advisory Letter to Balaji Amines on September 29, 2026. Company failed to disclose DGFT Denied Entity List order from August 2024 within 24 hours. Maharashtra FDA strict warning from January 2025 also went undisclosed for months. SEBI rejected company's claim that FDA letter was merely advisory in nature. No material financial impact reported by the company despite regulatory warnings.
12 days agoBalaji Amines receives FDA warning for technical grade product misuse
FDA issued a warning letter to Balaji Amines on January 10, 2025. No penalty, prosecution, or adverse order was passed against the company. Misuse involved technical grade Propylene Glycol diverted to pharma use. Company reports no material impact on financials or operations.
12 days agoBalaji Amines subsidiary director Tapadiya completes second term
Rajendrakumar Mohanprasad Tapadiya ceased as Independent Director of Balaji Speciality Chemicals on September 28, 2026. The exit followed the completion of his second term on the subsidiary's board. Disclosure made under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
15 days agoBalaji Amines starts commercial production at enhanced acetonitrile plant
Commercial production began at the Acetonitrile plant on September 24, 2026. Installed capacity increased to 1,440 tonnes per month. Plant is located at Unit III in Chincholi MIDC, Solapur. Product caters to both domestic and international markets.
19 days agoBalaji Amines hosts analyst meet and plant visit on August 25
Balaji Amines will host analysts and institutional investors for a plant visit and management meet on August 25, 2026, at its Solapur, Maharashtra facility. The event was disclosed to BSE and NSE pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Discussions will be confined strictly to publicly available information, with no unpublished price-sensitive information to be shared.
1mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,497.60 | +1.35% | ₹1,52,437.66 | 56.20 | -0.86% | |
| ₹2,492.00 | +0.14% | ₹73,869.07 | 33.91 | -17.61% | |
| ₹4,550.80 | -1.16% | ₹49,990.54 | 84.18 | +22.07% | |
| ₹8,468.00 | -1.09% | ₹43,434.38 | 55.68 | +78.61% | |
| ₹660.00 | -0.21% | ₹33,301.90 | 41.50 | +44.90% | |
| ₹1,715.70 | -3.57% | ₹22,772.12 | 100.43 | +128.70% | |
| ₹1,622.10 | +0.23% | ₹22,124.32 | 28.16 | -9.34% | |
| ₹487.80 | +2.93% | ₹17,687.36 | 32.37 | +29.05% | |
| ₹5,998.00 | +0.33% | ₹17,659.16 | 21.69 | -0.56% | |
| ₹5,422.50 | -1.44% | ₹16,625.37 | 38.52 | +16.41% | |
| ₹3,421.20 | +1.27% | ₹14,808.88 | 22.73 | -25.49% | |
| ₹1,165.00 | +1.16% | ₹13,263.51 | 58.35 | -8.09% |
An investment of ₹10,000 made 5 years ago in Balaji Amines is now worth
₹ 4,643.00
resulting in a loss of
₹ 5,357.00 (53.57%)
Note: Past profits do not guarantee future returns.